Lo Faro V, Bhattacharya A, Zhou W, Zhou D, Wang Y, Lall K
Cell Rep Med. 2024; 5(2):101430.
PMID: 38382466
PMC: 10897632.
DOI: 10.1016/j.xcrm.2024.101430.
Zhou H, Li L, Xie W, Wu L, Lin Y, He X
Onco Targets Ther. 2020; 13:10489-10498.
PMID: 33116628
PMC: 7573315.
DOI: 10.2147/OTT.S263090.
Meireles Da Costa N, Pinto L, Nasciutti L, Palumbo Jr A
Biomed Res Int. 2019; 2019:2059516.
PMID: 31737655
PMC: 6815579.
DOI: 10.1155/2019/2059516.
Kohl B, Zhong X, Herrmann C, Stoll R
Nucleic Acids Res. 2019; 47(22):11906-11920.
PMID: 31340016
PMC: 7145567.
DOI: 10.1093/nar/gkz614.
Junior A, de Sousa V, Esposito F, De Martino M, Forzati F, de Barros Moreira F
Genes (Basel). 2019; 10(5).
PMID: 31096664
PMC: 6562754.
DOI: 10.3390/genes10050372.
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.
Andreozzi M, Quintavalle C, Benz D, Quagliata L, Matter M, Calabrese D
Neoplasia. 2016; 18(12):724-731.
PMID: 27855356
PMC: 5110473.
DOI: 10.1016/j.neo.2016.10.002.
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter T, Xian L, Huso T, Koo M, Chang Y, Almasri T
Curr Mol Med. 2016; 16(4):353-93.
PMID: 26980699
PMC: 5408585.
DOI: 10.2174/1566524016666160316152147.
HMGA1-pseudogenes and cancer.
De Martino M, Forzati F, Arra C, Fusco A, Esposito F
Oncotarget. 2016; 7(19):28724-35.
PMID: 26895108
PMC: 5053758.
DOI: 10.18632/oncotarget.7427.
Polycomb protein family member CBX7 plays a critical role in cancer progression.
Pallante P, Forzati F, Federico A, Arra C, Fusco A
Am J Cancer Res. 2015; 5(5):1594-601.
PMID: 26175930
PMC: 4497428.
Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part I: clocks and clocking machinery.
Uth K, Sleigh R
Biotechnol Biotechnol Equip. 2015; 28(2):176-183.
PMID: 26019503
PMC: 4434034.
DOI: 10.1080/13102818.2014.915155.
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes.
Pierantoni G, Conte A, Rinaldo C, Tornincasa M, Gerlini R, Federico A
Oncotarget. 2015; 6(19):17342-53.
PMID: 26009897
PMC: 4627312.
DOI: 10.18632/oncotarget.3944.
High mobility group a proteins as tumor markers.
Pallante P, Sepe R, Puca F, Fusco A
Front Med (Lausanne). 2015; 2:15.
PMID: 25859543
PMC: 4373383.
DOI: 10.3389/fmed.2015.00015.
TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X, Zhong J, Tan J, Tan L, Yang D, Zhang Q
Int J Mol Med. 2015; 35(3):693-701.
PMID: 25572132
PMC: 4314408.
DOI: 10.3892/ijmm.2015.2062.
Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
Zhang Z, Wang Q, Chen F, Liu J
Tumour Biol. 2014; 36(2):1213-9.
PMID: 25344216
DOI: 10.1007/s13277-014-2749-4.
HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
Puca F, Colamaio M, Federico A, Gemei M, Tosti N, Bastos A
Oncotarget. 2014; 5(10):3234-45.
PMID: 24833610
PMC: 4102806.
DOI: 10.18632/oncotarget.1914.
The high mobility group A1 molecular switch: turning on cancer - can we turn it off?.
Huso T, Resar L
Expert Opin Ther Targets. 2014; 18(5):541-53.
PMID: 24684280
PMC: 4404637.
DOI: 10.1517/14728222.2014.900045.
Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F, Shin J, Harbom K, Brayton C
Biochem Biophys Res Commun. 2013; 434(1):70-4.
PMID: 23545254
PMC: 3662800.
DOI: 10.1016/j.bbrc.2013.03.064.
The hallmarks of cancer: a long non-coding RNA point of view.
Gutschner T, Diederichs S
RNA Biol. 2012; 9(6):703-19.
PMID: 22664915
PMC: 3495743.
DOI: 10.4161/rna.20481.
High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
Liau S, Whang E
Surgeon. 2009; 7(5):297-306.
PMID: 19848064
PMC: 3064443.
DOI: 10.1016/s1479-666x(09)80008-5.
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.
Mellone M, Rinaldi C, Massimi I, Petroni M, Veschi V, Talora C
Neoplasia. 2008; 10(8):773-81.
PMID: 18670638
PMC: 2481567.
DOI: 10.1593/neo.08462.